The addition of the MSC-B group to the experiment was due to the expectation of an additive therapeutic effect of the BDNF protein (immediate) and MSC microvesicles (delayed effect) during the long brain recovery process after the intracerebral hemorrhage. The gene discussed is BDNF; the disease is intracerebral hemorrhage.